Collection House Invests $8.5 Million for 4.5% Stake in Volt Bank

  • January 22, 2019 05:16 PM AEDT
  • Team Kalkine
Collection House Invests $8.5 Million for 4.5% Stake in Volt Bank

Collection House Limited (ASX: CLH), domiciled in Queensland, Australia, is a B2B receivable management company. The company caters to organizations and individuals and provides them credit management, collections, and customer care digital and data-driven solutions. The company offers professional, ethical, and effective products and services through its eight brands, the Collection House Limited, Lion Finance, CLH Lawyers, CLH Business Services, Collective Learning and Development, Think Me Finance, SafeHorizons, and Midstate Creditcollect Pty Ltd.

Today, the company has come up with a significant announcement. The company has made an equity investment in Volt Corporation Ltd (Volt) and has acquired a stake of approx. 4.5% through its investment of $8.5 million. Volt is the holding company of Volt Bank Ltd (Volt Bank). This investment is expected to have a marginal impact on CLH’s FY19 financial performance, but it has the potential to deliver $3 million of profit in FY20.

Volt Bank Ltd, based in Australia, is a newly established digital bank focussing on delivering a better, fairer, and safer way for its clients to manage their money. It is the first start-up, with no branches, to be licensed as a retail bank in the Australian market since 1981 and today, i.e., 22 January 2019, it has secured the Authorized Deposit-taking Institution (ADI) license from the Australian Prudential Regulation Authority (APRA). Till date, Volt Bank has gone through four rounds of capital funding and has raised more than $45 million in Tier 1 capital.

This investment is expected to enhance the strategic alliance between Volt Bank and CLH, announced on 29 November 2018, focussing on delivering ethical and innovative financial products and services to its customers. The strategic alliance will collaborate CLH’s C5 and call centre software and its debt collection portal to develop analytical tools and resources.

Both the companies have already collaborated their analytical tools and resources which will be available to customers after the Volt Bank launches its products this year. Key areas of interest for both companies are the digitization of hardship identification, assessment and treatment programs, and the integration of components of CLH’s market-leading Customer Portal.

As per the management of CLH, the investment was a part of the company’s ongoing digital transformation strategy further helping its customers to rehabilitate their finances without the burden of excessive interest rates and costs. This investment will also help the company to expand its collection services and analytical services divisions to offer new and innovative financial products and services to its customers.

The management of Volt Bank is also thrilled to strengthen its existing alliance with CLH.

Looking at Collection House Limited’s stock performance and the return it has posted over the last few months, the stock has generated a positive return of 3.08% over the past three months. It closed the day’s trading session at $1.360 with a surge of 1.866% following the news on 22 January 2019. The company has ~138.17 million shares outstanding with the market cap of circa $185.15 million. Its 52-week high and low are marked at $1.695 and $1.200 respectively. CLH has a P/E ratio of 6.98x and an annual dividend yield of 5.82%.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

 

With the pandemic continuing to affect the globe, healthcare companies are evaluating their lead compounds for COVID-19 treatment. Future revenue for these stocks depends on the probability of launching an approved treatment in the market.

CLICK HERE FOR YOUR FREE REPORT!

 

All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK